A Disintegrin And Metalloproteinase
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
</StructureSection> | </StructureSection> | ||
| - | == 3D Structures of A Disintegrin And Metalloproteinase == | ||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *ADAM5 | ||
| - | |||
| - | **[[3hy7]], [[3hyg]] – hADAM5 catalytic domain (mutant) - human<br /> | ||
| - | |||
| - | *ADAM8 | ||
| - | |||
| - | **[[4dd8]] – hADAM8 + batimastat<br /> | ||
| - | |||
| - | *ADAM10 | ||
| - | |||
| - | **[[2ao7]] – bADAM10 - bovine<br /> | ||
| - | **[[6be6]] – hADAM10 <br /> | ||
| - | **[[5l0q]] – bADAM10 + antibody<br /> | ||
| - | **[[6bdz]] – hADAM10 + antibody<br /> | ||
| - | |||
| - | *ADAM17 or TACE or TNF-alpha converting enzyme | ||
| - | |||
| - | **[[2m2f]] – hADAM17 membrane-proximal domain - NMR<br /> | ||
| - | **[[1zxc]], [[2a8h]], [[2ddf]], [[1bkc]] – hADAM17 catalytic domain + inhibitor <br /> | ||
| - | **[[2fv5]], [[2fv9]], [[2i47]], [[3b92]], [[3cki]], [[3e8r]], [[3edz]], [[3ewj]], [[3g42]], [[3l0t]], [[3l0v]], [[3le9]], [[3lea]], [[3lgp]], [[3kmc]], [[3kme]], [[3o64]], [[2oi0]] - hADAM17 catalytic domain (mutant)+ inhibitor<br /> | ||
| - | **[[3cki]] - hADAM17 catalytic domain (mutant) + protein inhibitor<br /> | ||
| - | |||
| - | *ADAM22 | ||
| - | |||
| - | **[[3g5c]] - hADAM22 ectodomain<br /> | ||
| - | **[[5y31]], [[5y2z]] – hADAM22 ectodomain + LGI1<br /> | ||
| - | |||
| - | *ADAM33 | ||
| - | |||
| - | **[[1r54]], [[1r55]] – hADAM33 catalytic domain<br /> | ||
| - | |||
| - | *ADAMTS1 | ||
| - | |||
| - | **[[2jih]], [[3q2g]], [[3q2h]] - hADAMTS1 catalytic domain + inhibitor<br /> | ||
| - | **[[2v4b]] - hADAMTS1 catalytic domain | ||
| - | |||
| - | *ADAMTS4 | ||
| - | |||
| - | **[[3b2z]] - hADAMTS4 residues 213-520<br /> | ||
| - | **[[4wk7]], [[4wke]], [[4wki]] - hADAMTS4 residues 213-439 +inhibitor<br /> | ||
| - | **[[2rjp]] - hADAMTS4 residues 213-520 (mutant) + inhibitor | ||
| - | |||
| - | *ADAMTS5 | ||
| - | |||
| - | **[[2rjq]] - hADAMTS5 residues 262-628 + inhibitor<br /> | ||
| - | **[[3b8z]], [[3hy7]], [[3hy9]], [[3hyg]], [[3ljt]] - hADAMTS5 catalytic domain (mutant) + inhibitor | ||
| - | |||
| - | *ADAMTS13 | ||
| - | |||
| - | **[[3ghm]], [[3ghn]], [[3vn4]] - hADAMTS13 exosite-containing fragment (mutant)<br /> | ||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 10:24, 24 February 2019
| |||||||||||
References
- ↑ Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med. 2008 Oct;29(5):258-89. doi: 10.1016/j.mam.2008.08.001. Epub 2008, Aug 15. PMID:18762209 doi:http://dx.doi.org/10.1016/j.mam.2008.08.001
